Generics in Singapore
Generics in SingaporeSummary
Generics in Singapore industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Synopsis
Essential resource for top-line data and analysis covering the Singapore generics market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
Key Highlights
- For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.
- The Singaporean generics market had total revenues of $341.1m in 2017, representing a compound annual growth rate (CAGR) of 8.2% between 2013 and 2017.
- Market consumption volume increased with a CAGR of 0.6% between 2013 and 2017, to reach a total of 88.2% in 2017.
- Growth in the Singaporean pharmaceuticals market has helped the city-state become a regional hub for the manufacturing, research, and development for multinational pharmaceutical companies.
Scope
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the generics market in Singapore
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in Singapore
- Leading company profiles reveal details of key generics market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Singapore generics market with five year forecasts by both value and volume
Reasons to buy
- What was the size of the Singapore generics market by value in 2017?
- What will be the size of the Singapore generics market in 2022?
- What factors are affecting the strength of competition in the Singapore generics market?
- How has the market performed over the last five years?
- How large is Singapore’s generics market in relation to its regional counterparts?
MarketLine, a world-leading provider of commercial intelligence, has over 400 experienced analysts, consultants, and researchers with regional and sector expertise in market sizing, competitor tracking, socio and macro economics, and business drivers.
For more than 15 years MarketLine has supported the research needs of investment banks, corporations, professional services firms, and academia with a unique mix of company, industry, country, city and financial data for every major industry and marketplace.
MarketLine’ holistic business intelligence report collection includes:
Industry Intelligence
‒ Industry Profiles
‒ Market Forecasts
‒ Porter’s Five Forces Analysis
Company Intelligence
‒ Company Profiles
‒ SWOT Analysis
‒ Financial Deals
Country and City Intelligence
‒ Country and City Profiles
‒ PEST/PESTLE Analysis
‒ Socio and macro-economic indicators
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.